MLTI-16. SYSTEMIC THERAPY FOLLOWING CRANIOTOMY IN PATIENTS WITH A SOLITARY BREAST CANCER BRAIN METASTASIS

INTRODUCTION: Between 15–50% of patients with metastatic breast cancer will develop brain metastases, with the frequency more common in patients with HER2-positive or triple-negative subtypes. Surgical resection is often indicated for diagnostic and/or therapeutic intent for patients presenting with...

Descripción completa

Detalles Bibliográficos
Autores principales: Hulsbergen, Alexander, Cho, Logan, Mammi, Marco, Lamba, Nayan, Smith, Timothy, Broekman, Marike, Lin, Nancy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213430/
http://dx.doi.org/10.1093/noajnl/vdz014.075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213430/
http://dx.doi.org/10.1093/noajnl/vdz014.075

Ejemplares similares